130 related articles for article (PubMed ID: 37477039)
1. Delayed Surgical Intervention After Chemoradiotherapy in Esophageal Cancer: (DICE) Study.
Chidambaram S; Owen R; Sgromo B; Chmura M; Kisiel A; Evans R; Griffiths EA; Castoro C; Gronnier C; MaoAwyes MA; Gutschow CA; Piessen G; Degisors S; Alvieri R; Feldman H; Capovilla G; Grimminger PP; Han S; Low DE; Moore J; Gossage J; Voeten D; Gisbertz SS; Ruurda J; van Hillegersberg R; D'Journo XB; Chmelo J; Phillips AW; Rosati R; Hanna GB; Maynard N; Hofstetter W; Ferri L; Berge Henegouwen MI; Markar SR
Ann Surg; 2023 Nov; 278(5):701-708. PubMed ID: 37477039
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment Esophageal Wall Thickness Associated with Response to Chemoradiotherapy in Locally Advanced Esophageal Cancer.
Wongwaiyut K; Ruangsin S; Laohawiriyakamol S; Leelakiatpaiboon S; Sangthawan D; Sunpaweravong P; Sunpaweravong S
J Gastrointest Cancer; 2020 Sep; 51(3):947-951. PubMed ID: 31758468
[TBL] [Abstract][Full Text] [Related]
3. Impact of Chemoradiation-induced Myelosuppression on Prognosis of Patients with Locally Advanced Esophageal Cancer After Chemoradiotherapy Followed by Esophagectomy.
Ohira M; Kubo N; Yamashita Y; Sakurai K; Toyokawa T; Tanaka H; Muguruma K; Hirakawa K
Anticancer Res; 2015 Sep; 35(9):4889-95. PubMed ID: 26254384
[TBL] [Abstract][Full Text] [Related]
4. Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study.
Luc G; Gronnier C; Lebreton G; Brigand C; Mabrut JY; Bail JP; Meunier B; Collet D; Mariette C
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1357-64. PubMed ID: 26014152
[TBL] [Abstract][Full Text] [Related]
5. Impact of Chemoradiation-to-Surgery Interval on Pathological Complete Response and Short- and Long-Term Overall Survival in Esophageal Cancer Patients.
Azab B; Amundson JR; Picado O; Ripat C; Macedo FI; Franceschi D; Livingstone AS; Yakoub D
Ann Surg Oncol; 2019 Mar; 26(3):861-868. PubMed ID: 30311162
[TBL] [Abstract][Full Text] [Related]
6. Real-world management and outcomes of older patients with locally advanced esophageal squamous cell carcinoma: a multicenter retrospective study.
Saito Y; Hamamoto Y; Hirata K; Yamasaki M; Watanabe M; Abe T; Tsubosa Y; Hamai Y; Murakami K; Bamba T; Yoshii T; Tsuda M; Watanabe M; Ueno M; Kitagawa Y
BMC Cancer; 2023 Mar; 23(1):283. PubMed ID: 36978040
[TBL] [Abstract][Full Text] [Related]
7. Association between time interval from neoadjuvant chemoradiotherapy to surgery and complete histological tumor response in esophageal and gastroesophageal junction cancer: a national cohort study.
Klevebro F; Nilsson K; Lindblad M; Ekman S; Johansson J; Lundell L; Ndegwa N; Hedberg J; Nilsson M
Dis Esophagus; 2020 May; 33(5):. PubMed ID: 31676895
[TBL] [Abstract][Full Text] [Related]
8. Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma.
Barbetta A; Hsu M; Tan KS; Stefanova D; Herman K; Adusumilli PS; Bains MS; Bott MJ; Isbell JM; Janjigian YY; Ku GY; Park BJ; Wu AJ; Jones DR; Molena D
J Thorac Cardiovasc Surg; 2018 Jun; 155(6):2710-2721.e3. PubMed ID: 29548582
[TBL] [Abstract][Full Text] [Related]
9. The Prognostic Impact of Minimally Invasive Esophagectomy on Survival after Esophagectomy following a Delayed Interval after Chemoradiotherapy; A Secondary Analysis of the DICE Study.
Markar SR; Sgromo B; Evans R; Griffiths EA; Alfieri R; Castoro C; Gronnier C; Gutschow CA; Piessen G; Capovilla G; Grimminger PP; Low DE; Gossage J; Gisbertz SS; Ruurda J; van Hillegersberg R; D'journo XB; Phillips AW; Rosati R; Hanna GB; Maynard N; Hofstetter W; Ferri L; Berge Henegouwen MI; Owen R
Ann Surg; 2024 Jun; ():. PubMed ID: 38904105
[TBL] [Abstract][Full Text] [Related]
10. Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer?
Lee A; Wong AT; Schwartz D; Weiner JP; Osborn VW; Schreiber D
Ann Thorac Surg; 2016 Aug; 102(2):433-8. PubMed ID: 27154156
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial.
Yang H; Liu H; Chen Y; Zhu C; Fang W; Yu Z; Mao W; Xiang J; Han Y; Chen Z; Yang H; Wang J; Pang Q; Zheng X; Yang H; Li T; Lordick F; D'Journo XB; Cerfolio RJ; Korst RJ; Novoa NM; Swanson SJ; Brunelli A; Ismail M; Fernando HC; Zhang X; Li Q; Wang G; Chen B; Mao T; Kong M; Guo X; Lin T; Liu M; Fu J;
J Clin Oncol; 2018 Sep; 36(27):2796-2803. PubMed ID: 30089078
[TBL] [Abstract][Full Text] [Related]
12. Outcome of delayed versus timely esophagectomy after chemoradiation for esophageal adenocarcinoma.
Levinsky NC; Wima K; Morris MC; Ahmad SA; Shah SA; Starnes SL; Van Haren RM;
J Thorac Cardiovasc Surg; 2020 Jun; 159(6):2555-2566. PubMed ID: 31767364
[TBL] [Abstract][Full Text] [Related]
13. Utility of weekly docetaxel combined with preoperative radiotherapy for locally advanced esophageal cancer from pathological analysis.
Kushida T; Nohara S; Yoshino K; Fujiwara D; Ouchi K; Amano T; Isayama F; Tomita N; Iwanuma Y; Sasai K; Tsurumaru M; Kajiyama Y
Dis Esophagus; 2014; 27(4):368-73. PubMed ID: 23865505
[TBL] [Abstract][Full Text] [Related]
14. A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
Sanford NN; Catalano PJ; Enzinger PC; King BL; Bueno R; Martin NE; Hong TS; Wo JY; Mamon HJ
Dis Esophagus; 2017 Jul; 30(7):1-8. PubMed ID: 28475728
[TBL] [Abstract][Full Text] [Related]
15. [Is esophagectomy necessary for esophageal cancer patients with complete response after neoadjuvant chemoradiotherapy].
Fu J; Tan Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):983-986. PubMed ID: 30269316
[TBL] [Abstract][Full Text] [Related]
16. Association of Intervals Between Neoadjuvant Chemoradiation and Surgical Resection With Pathologic Complete Response and Survival in Patients With Esophageal Cancer.
Haisley KR; Laird AE; Nabavizadeh N; Gatter KM; Holland JM; Vaccaro GM; Thomas CR; Schipper PH; Hunter JG; Dolan JP
JAMA Surg; 2016 Nov; 151(11):e162743. PubMed ID: 27627765
[TBL] [Abstract][Full Text] [Related]
17. Results of Neoadjuvant Chemoradiotherapy With Docetaxel and 5-Fluorouracil Followed by Esophagectomy to Treat Locally Advanced Esophageal Cancer.
Hamai Y; Hihara J; Emi M; Murakami Y; Kenjo M; Nagata Y; Okada M
Ann Thorac Surg; 2015 Jun; 99(6):1887-93. PubMed ID: 25912745
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of planned esophagectomy after neoadjuvant chemoradiotherapy for advanced esophageal carcinomas.
Kato H; Fukuchi M; Manda R; Faried A; Takita J; Nakajima M; Miyazaki T; Sohda M; Fukai Y; Masuda N; Tsukada K; Kuwano H
Anticancer Res; 2004; 24(6):4091-6. PubMed ID: 15736457
[TBL] [Abstract][Full Text] [Related]
19. Impact of pathological tumor response after CROSS neoadjuvant chemoradiotherapy followed by surgery on long-term outcome of esophageal cancer: a population-based study.
Al-Kaabi A; van der Post RS; van der Werf LR; Wijnhoven BPL; Rosman C; Hulshof MCCM; van Laarhoven HWM; Verhoeven RHA; Siersema PD
Acta Oncol; 2021 Apr; 60(4):497-504. PubMed ID: 33491513
[TBL] [Abstract][Full Text] [Related]
20. It's not always too late: a case for minimally invasive salvage esophagectomy.
Broderick RC; Lee AM; Blitzer RR; Zhao B; Lam J; Cheverie JN; Sandler BJ; Jacobsen GR; Onaitis MW; Kelly KJ; Bouvet M; Horgan S
Surg Endosc; 2021 Aug; 35(8):4700-4711. PubMed ID: 32940794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]